Find Reports
Select Report Type
Reimbursement Review
Displaying 1251 - 1275 of 1426
Please scroll or swipe to the right to view the full content.
| Title | Brand Name | Generic Name | Files | Therapeutic Area | Recommendation Type | Status | Submission Date | Recommendation Date Sort ascending | Project Number |
|---|---|---|---|---|---|---|---|---|---|
| CADTH Pharmaceutical Reviews U... | |||||||||
| fluticasone furoate/vilanterol | Breo Ellipta | fluticasone furoate/vilanterol | Asthma | Withdrawn | SR0568-000 | ||||
| pembrolizumab | Keytruda | pembrolizumab | Gastrointestinal Cancer | Canada’s Drug Agency is unable to make a reimbursement recommendation as the manufacturer has not filed a submission. | Not filed | NS0012-000 | |||
| Rituximab for Non-Hodgkin’s Ly... | TBD | Rituximab | Cancelled | PC0180-000 | |||||
| CADTH Pharmaceutical Reviews U... | |||||||||
| CADTH Pharmaceutical Reviews U... | |||||||||
| CADTH Pharmaceutical Reviews U... | |||||||||
| Optimal Pharmacotherapy for Tr... | Optimal Pharmacotherapy for Transplant-Ineligible Multiple Myeloma | Complete | TR0014-000 - OP0547-000 | ||||||
| lurasidone | Latuda | lurasidone | Bipolar I disorder | Canada’s Drug Agency is unable to make a reimbursement recommendation as the manufacturer has not filed a submission. | Not filed | NS0010-000 | |||
| tofacitinib | Xeljanz | tofacitinib | Cancelled | SR0575-000 | |||||
| Beleodaq for Peripheral T-Cell... | Beleodaq | Belinostat | Withdrawn | PC0139-000 | |||||
| Blincyto for MRD-positive B-ce... | Blincyto | Blinatumomab | Withdrawn | PC0143-000 | |||||
| Nelarabine for Acute Lymphobla... | Atriance | Nelarabine | Cancelled | PC0170-000 | |||||
| CADTH Pharmaceutical Reviews U... | |||||||||
| ravulizumab | TBC | ravulizumab | Paroxysmal nocturnal hemoglobinuria. | Withdrawn | SR0623-000 | ||||
| decitabine | Demylocan | decitabine | Myelodysplastic Syndromes | Canada’s Drug Agency is unable to make a reimbursement recommendation as the manufacturer has not filed a submission. | Not filed | NS0001-000 | |||
| Cabozantinib for Advanced Rena... | TBD | Cabozantinib | Withdrawn | PC0123-000 | |||||
| cyclosporine | Ikervis | cyclosporine | keratitis, severe | Withdrawn | SR0518-000 | ||||
| fluticasone furoate/vilanterol | Breo Ellipta | fluticasone furoate/vilanterol | COPD | Withdrawn | SR0524-000 | ||||
| RFA: Bosulif for Chronic Myelo... | Bosulif (RFA) | Bosutinib | Chronic Myeloid Leukemia | N/A | Complete | PA0002-000 | |||
| Trastuzumab for Breast and Gas... | TBD | Trastuzumab | Cancelled | PC0160-000 | |||||
| CADTH Pharmaceutical Reviews U... | |||||||||
| Rituximab (Truxima) for Non-Ho... | Truxima | Rituximab | Cancelled | PC0184-000 | |||||
| Bevacizumab (TBD) mCRC NSCLC B... | TBD | Bevacizumab | Cancelled | PC0178-000 | |||||
| CADTH Pharmaceutical Reviews U... |
Health Technology Review
Displaying 601 - 602 of 602
Horizon Scan
Displaying 101 - 110 of 110
Projects in Progress
Displaying 26 - 27 of 27
View All Reports
Displaying 1251 - 1275 of 2138
Please scroll or swipe to the right to view the full content.
Provisional Funding Algorithm
Displaying 76 - 81 of 81